Doug Koo

Doug Koo is an accomplished finance executive with extensive experience in the healthcare sector. Currently serving as Managing Director and Chief Financial Officer at Ajax Health since May 2017, and also holding the CFO position at Ablacon, Inc. since April 2019, Koo has a proven track record in financial leadership. Previous roles include CFO at Advanced Cardiac Therapeutics, Inc. until its acquisition by Medtronic, and at Spirox, acquired by Entellus, as well as CV Ingenuity, which was acquired by Covidien. Additional experience includes financial leadership at TauTona Group and Managing Director at Leader Ventures. Koo's educational background features a graduate degree from Stanford University Graduate School of Business and a BA in Management Science from UC San Diego.